Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Highlights from Greenlight’s Q3 Letter (Part 2): Einhorn’s New Picks and Two Stocks He Is Shorting

Page 1 of 2

We have obtained the third quarter letter to investors of David Einhorn‘s Greenlight Capital and decided to take a look at some of the picks that the investor outlined within its pages. In the previous article we analyzed some of Greenlight’s tech picks, many of which significantly affected its returns during the third quarter, as well as year-to-date (see the article here). As we have already mentioned, Greenlight’s funds lost 14.3% during the third quarter. In this article, we will take a look at two of the new positions outlined in the letter, as well as one of its largest holdings and two stocks that Einhorn has shorted.

See the first part here.

See the third part here.

David Einhorn
David Einhorn
Greenlight Capital

David Einhorn

Michael Kors Holdings Ltd (NYSE:KORS) was one of the new picks mentioned in Greenlight’s previous 13F filing. The investor reported ownership of 3.62 million shares. Einhorn initiated a stake after Michael Kors Holdings Ltd (NYSE:KORS)’s stock lost 25% on the back of a 5.8% decline in comparable-store sales reported for the first quarter. The company also shut down a distribution center, which caused a temporary halt in its e-commerce segment and customer interest also declined on the back of a repetitive winter product line. However, Greenlight believes that Michael Kors Holdings Ltd (NYSE:KORS) overcame those issues.

Follow Michael Kors Holdings Ltd (NYSE:KORS)
Trade (NYSE:KORS) Now!

“We believe KORS has multiple avenues of continued growth, including its international business and footwear. We established our position at an average price of $45.18, less than 9.5x March 2016 fiscal year earnings estimates net of the $4 per share in cash,” Greenlight said.

The other new holding in Greenlight’s portfolio was UIL Holdings Corporation (NYSE:UIL), in which Greenlight reported a new stake in its 13F for the first quarter. During the second quarter, the fund almost doubled its position to 4.99 million shares. According to the letter, Greenlight acquired the stake at an average price of $49.57. UIL Holdings Corporation (NYSE:UIL)’s stock is up by 15% year-to-date and currently trades around $50.50. The investor believes that the combination with Iberdola USA, which has regulated utility assets in the Northeast and holds one of the largest wind energy portfolios in the U.S, will benefit the shareholders of UIL Holdings Corporation (NYSE:UIL), since the new entity will be “less levered than its peers with a large tax asset and attractive renewables cash flows that we believe are not fully reflected in the stock price today.”

Follow Uil Holdings Corp (NYSE:UIL)
Trade (NYSE:UIL) Now!

Read on to see Greenlight’s opinion about General Motors Company (NYSE:GM), which represents one of its largest holdings, as well as two companies in which it has short positions, namely athenahealth, Inc (NASDAQ:ATHN), and Keurig Green Mountain Inc (NASDAQ:GMCR). It’s important to mention that Greenlight currently has short exposure of around 66%. Einhorn’s short positions are a separate story, since the investor only discloses them during interviews, at conferences, and in letters. Over the years, Einhorn has managed to make a number of successful short bets, such as his call on the Lehman Brothers’ bankruptcy.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!